March 27, 2024
Japan’s health ministry doled out approval for a raft of new medicines and label expansions on March 26, including Chugai Pharmaceutical’s Piasky (crovalimab), Astellas Pharma’s Vyloy (zolbetuximab), as well as an older adult indication for Pfizer’s RSV vaccine Abrysvo. The...read more